Form D · Other Technology
Rejuvatek Medical Inc.
Sandy, UT · CIK 0001781709
Offering snapshot reported Mar 23, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Sep 10, 2020 | Initial | $150,000 | No comparison | 3 | SEC filing |
| Jul 11, 2019 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577389
Source: Form D, filed Mar 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kerry Assil | Director |
| Bradley Bertoch | Director |
| William Kelley | Director |
| William K. Kelly | Director |
| Jack Savage | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8160 S. Highland Drive Bldg. A, Suite A 2
Sandy, UT, 84093
Sandy, UT, 84093